Search

Your search keyword '"Hoyer, Bimba F."' showing total 211 results
Start Over Author "Hoyer, Bimba F."
211 results on '"Hoyer, Bimba F."'

2. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Author

Sattui, Sebastian E, Conway, Richard, Putman, Michael S, Seet, Andrea M, Gianfrancesco, Milena A, Beins, Kaley, Hill, Catherine, Liew, David, Mackie, Sarah L, Mehta, Puja, Neill, Lorna, Gomez, Gimena, Salinas, Maria Isabel Haye, Maldonado, Federico Nicolas, Mariz, Henrique Ataide, de Sousa Studart, Samia Araujo, Araujo, Nafice Costa, Knight, Ann, Rozza, Davide, Quartuccio, Luca, Samson, Maxime, Bally, Stéphane, Maria, Alexandre TJ, Chazerain, Pascal, Hasseli, Rebecca, Müller-Ladner, Ulf, Hoyer, Bimba F, Voll, Reinhard, Torres, Rita Pinheiro, Luis, Mariana, Ribeirio, Sandra Lucia Euzebio, Al-Emadi, Samar, Sparks, Jeffrey A, Hsu, Tiffany Y-T, D’Silva, Kristin M, Patel, Naomi J, Wise, Leanna, Gilbert, Emily, Almada, Maria Valenzuela, Duarte-García, Alí, Ugarte-Gil, Manuel, Jacobsohn, Lindsay, Izadi, Zara, Strangfeld, Anja, Mateus, Elsa F, Hyrich, Kimme L, Gossec, Laure, Carmona, Loreto, Lawson-Tovey, Saskia, Kearsley-Fleet, Lianne, Schaefer, Martin, Sirotich, Emily, Hausmann, Jonathan S, Sufka, Paul, Bhana, Suleman, Liew, Jean W, Grainger, Rebecca, Machado, Pedro M, Wallace, Zachary S, Yazdany, Jinoos, Robinson, Philip C, Alliance, Global Rheumatology, Dahou, Brahim, Rath, Eva, Piette, Yves, Devinck, Mieke, Maeyaert, Bea, Ribeiro, Francinne Machado, Ribeiro, Sandra Lucia Euzebio, Pinheiro, Marcelo, Quintana, Rosana, Gómez, Gimena, Roberts, Karen, Baez, Roberto Miguel, Coello, Vanessa Castro, Salinas, María J Haye, Torres, Alvaro Andres Reyes, Alle, Gelsomina, Tanten, Romina, Ficco, Hernán Maldonado, Nieto, Romina, Gobbi, Carla, Tissera, Yohana, Pisoni, Cecilia, Paula, Alba, Albiero, Juan Alejandro, Schmid, Maria Marcela, Cosatti, Micaela, Gamba, Maria Julieta, Leandro, Carlevaris, Cusa, María Alejandra, German, Noelia, Bellomio, Veronica, Takashima, Lorena, Pera, Mariana, Cogo, Karina, Elkin, Maria Soledad Gálvez, Medina, María Alejandra, and Savio, Veronica

Subjects
Aging, Arthritis, Autoimmune Disease, Clinical Research, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Inflammatory and immune system, Global Rheumatology Alliance
Abstract

BackgroundPatients with primary systemic vasculitis or polymyalgia rheumatica might be at a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ damage cause by primary systemic vasculitis, and the demographic factors associated with these conditions. We therefore aimed to investigate factors associated with COVID-19 outcomes in patients with primary systemic vasculitis or polymyalgia rheumatica.MethodsIn this retrospective cohort study, adult patients (aged ≥18 years) diagnosed with COVID-19 between March 12, 2020, and April 12, 2021, who had a history of primary systemic vasculitis (antineutrophil cytoplasmic antibody [ANCA]-associated vasculitis, giant cell arteritis, Behçet's syndrome, or other vasculitis) or polymyalgia rheumatica, and were reported to the COVID-19 Global Rheumatology Alliance registry were included. To assess COVID-19 outcomes in patients, we used an ordinal COVID-19 severity scale, defined as: (1) no hospitalisation; (2) hospitalisation without supplemental oxygen; (3) hospitalisation with any supplemental oxygen or ventilation; or (4) death. Multivariable ordinal logistic regression analyses were used to estimate odds ratios (ORs), adjusting for age, sex, time period, number of comorbidities, smoking status, obesity, glucocorticoid use, disease activity, region, and medication category. Analyses were also stratified by type of rheumatic disease.FindingsOf 1202 eligible patients identified in the registry, 733 (61·0%) were women and 469 (39·0%) were men, and their mean age was 63·8 years (SD 17·1). A total of 374 (31·1%) patients had polymyalgia rheumatica, 353 (29·4%) had ANCA-associated vasculitis, 183 (15·2%) had giant cell arteritis, 112 (9·3%) had Behçet's syndrome, and 180 (15·0%) had other vasculitis. Of 1020 (84·9%) patients with outcome data, 512 (50·2%) were not hospitalised, 114 (11·2%) were hospitalised and did not receive supplemental oxygen, 239 (23·4%) were hospitalised and received ventilation or supplemental oxygen, and 155 (15·2%) died. A higher odds of poor COVID-19 outcomes were observed in patients who were older (per each additional decade of life OR 1·44 [95% CI 1·31-1·57]), were male compared with female (1·38 [1·05-1·80]), had more comorbidities (per each additional comorbidity 1·39 [1·23-1·58]), were taking 10 mg/day or more of prednisolone compared with none (2·14 [1·50-3·04]), or had moderate, or high or severe disease activity compared with those who had disease remission or low disease activity (2·12 [1·49-3·02]). Risk factors varied among different disease subtypes.InterpretationAmong patients with primary systemic vasculitis and polymyalgia rheumatica, severe COVID-19 outcomes were associated with variable and largely unmodifiable risk factors, such as age, sex, and number of comorbidities, as well as treatments, including high-dose glucocorticoids. Our results could be used to inform mitigation strategies for patients with these diseases.FundingAmerican College of Rheumatology and the European Alliance of Associations for Rheumatology.

Published
2021

3. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

Author

Hausmann, Jonathan S, Kennedy, Kevin, Simard, Julia F, Liew, Jean W, Sparks, Jeffrey A, Moni, Tarin T, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Sattui, Sebastian E, Semalulu, Teresa, Foster, Gary, Surangiwala, Salman, Thabane, Lehana, Beesley, Richard P, Durrant, Karen L, Mateus, Elsa F, Mingolla, Serena, Nudel, Michal, Palmerlee, Candace A, Richards, Dawn P, Liew, David FL, Hill, Catherine L, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Sirotich, Emily, Alliance, COVID-19 Global Rheumatology, Sufka, Paul H, Singh, Namrata, Howard, Richard A, Kim, Alfred HJ, Westrich-Robertson, Tiffany, Tsui, Edmund, Duarte-Garcia, Ali, Tam, Herman, Jayatilleke, Arundathi, Konig, Maximilian F, Graef, Elizabeth R, Putman, Michael S, Syed, Reema H, Korsten, Peter, Mateus, Elsa, Laura, Upton A, Adam, Kilian, Chock, Yu Pei Eugenia, White, Douglas W, Zamora, Geraldine T, Traboco, Lisa S, Patel, Aarat M, Ugarte-Gil, Manuel F, Gianfrancesco, Milena A, Amigues, Isabelle, Sanchez-Alvarez, Catalina, Trupin, Laura, Jacobsohn, Lindsay R, Hoyer, Bimba F, Makan, Kavita, Gossec, Laure, Priyank, Chaudhary, Leipe, Jan, Wallace, Beth, Angeles-Han, Sheila T, Almaghlouth, Ibrahim A, Katherine, Wysham D, Padula, Anthony S, Berenbaum, Francis, Treemarcki, Erin M, Sinha, Rashmi, Lewandowski, Laura B, Webb, Kate, Young, Kristen J, Bulina, Inita, Uribe, Sebastian Herrera, Rubinstein, Tamar B, Nolan, Marc W, Ang, Elizabeth Y, Venuturupalli, Swamy R, Dubreuil, Maureen, Pisoni, Cecilia N, Cosatti, Micaela A, Campos, Jose, and Conway, Richard

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Arthritis, Autoimmune Disease, Coronaviruses, Infectious Diseases, Emerging Infectious Diseases, Aging, Coronaviruses Disparities and At-Risk Populations, Women's Health, 7.1 Individual care needs, Generic health relevance, Inflammatory and immune system, Good Health and Well Being, COVID-19 Global Rheumatology Alliance, Clinical sciences
Abstract

BackgroundThe impact and consequences of the COVID-19 pandemic on people with rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance Patient Experience Survey to assess the effects of the COVID-19 pandemic on people with rheumatic disease worldwide.MethodsSurvey questions were developed by key stakeholder groups and disseminated worldwide through social media, websites, and patient support organisations. Questions included demographics, rheumatic disease diagnosis, COVID-19 diagnosis, adoption of protective behaviours to mitigate COVID-19 exposure, medication access and changes, health-care access and communication with rheumatologists, and changes in employment or schooling. Adults age 18 years and older with inflammatory or autoimmune rheumatic diseases were eligible for inclusion. We included participants with and without a COVID-19 diagnosis. We excluded participants reporting only non-inflammatory rheumatic diseases such as fibromyalgia or osteoarthritis.Findings12 117 responses to the survey were received between April 3 and May 8, 2020, and of these, 10 407 respondents had included appropriate age data. We included complete responses from 9300 adults with rheumatic disease (mean age 46·1 years; 8375 [90·1%] women, 893 [9·6%] men, and 32 [0·3%] participants who identified as non-binary). 6273 (67·5%) of respondents identified as White, 1565 (16·8%) as Latin American, 198 (2·1%) as Black, 190 (2·0%) as Asian, and 42 (0·5%) as Native American or Aboriginal or First Nation. The most common rheumatic disease diagnoses included rheumatoid arthritis (3636 [39·1%] of 9300), systemic lupus erythematosus (2882 [31·0%]), and Sjögren's syndrome (1290 [13·9%]). Most respondents (6921 [82·0%] of 8441) continued their antirheumatic medications as prescribed. Almost all (9266 [99·7%] of 9297) respondents adopted protective behaviours to limit SARS-CoV-2 exposure. A change in employment status occurred in 2524 (27·1%) of 9300) of respondents, with a 13·6% decrease in the number in full-time employment (from 4066 to 3514).InterpretationPeople with rheumatic disease maintained therapy and followed public health advice to mitigate the risks of COVID-19. Substantial employment status changes occurred, with potential implications for health-care access, medication affordability, mental health, and rheumatic disease activity.FundingAmerican College of Rheumatology.

Published
2021

4. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Author

Sattui, Sebastian Eduardo, Liew, Jean W, Kennedy, Kevin, Sirotich, Emily, Putman, Michael, Moni, Tarin T, Akpabio, Akpabio, Alpízar-Rodríguez, Deshiré, Berenbaum, Francis, Bulina, Inita, Conway, Richard, Singh, Aman Dev, Duff, Eimear, Durrant, Karen L, Gheita, Tamer A, Hill, Catherine L, Howard, Richard A, Hoyer, Bimba F, Hsieh, Evelyn, Kibbi, Lina El, Kilian, Adam, Kim, Alfred Hyoungju, Liew, David FL, Lo, Chieh, Miller, Bruce, Mingolla, Serena, Nudel, Michal, Palmerlee, Candace A, Singh, Jasvinder A, Singh, Namrata, Ugarte-Gil, Manuel Francisco, Wallace, John, Young, Kristen J, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Harrison, Carly, Larché, Maggie, Levine, Mitchell, Foster, Gary, Thabane, Lehana, Rider, Lisa G, Hausmann, Jonathan S, Simard, Julia F, and Sparks, Jeffrey A

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Prevention, Arthritis, Infectious Diseases, Autoimmune Disease, Vaccine Related, Emerging Infectious Diseases, Coronaviruses Vaccines, Patient Safety, Women's Health, Coronaviruses, Aging, Immunization, 6.1 Pharmaceuticals, 3.4 Vaccines, Inflammatory and immune system, Good Health and Well Being, Adult, COVID-19, COVID-19 Vaccines, Female, Humans, Male, Middle Aged, Rheumatic Diseases, Rheumatology, SARS-CoV-2, Surveys and Questionnaires, Vaccination, vaccination, autoimmune diseases, Clinical sciences
Abstract

BackgroundWe describe the early experiences of adults with systemic rheumatic disease who received the COVID-19 vaccine.MethodsFrom 2 April to 30 April 2021, we conducted an online, international survey of adults with systemic rheumatic disease who received COVID-19 vaccination. We collected patient-reported data on clinician communication, beliefs and intent about discontinuing disease-modifying antirheumatic drugs (DMARDs) around the time of vaccination, and patient-reported adverse events after vaccination.ResultsWe analysed 2860 adults with systemic rheumatic diseases who received COVID-19 vaccination (mean age 55.3 years, 86.7% female, 86.3% white). Types of COVID-19 vaccines were Pfizer-BioNTech (53.2%), Oxford/AstraZeneca (22.6%), Moderna (21.3%), Janssen/Johnson & Johnson (1.7%) and others (1.2%). The most common rheumatic disease was rheumatoid arthritis (42.3%), and 81.2% of respondents were on a DMARD. The majority (81.9%) reported communicating with clinicians about vaccination. Most (66.9%) were willing to temporarily discontinue DMARDs to improve vaccine efficacy, although many (44.3%) were concerned about rheumatic disease flares. After vaccination, the most reported patient-reported adverse events were fatigue/somnolence (33.4%), headache (27.7%), muscle/joint pains (22.8%) and fever/chills (19.9%). Rheumatic disease flares that required medication changes occurred in 4.6%.ConclusionAmong adults with systemic rheumatic disease who received COVID-19 vaccination, patient-reported adverse events were typical of those reported in the general population. Most patients were willing to temporarily discontinue DMARDs to improve vaccine efficacy. The relatively low frequency of rheumatic disease flare requiring medications was reassuring.

Published
2021

6. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

Author

Aringer, Martin, Costenbader, Karen, Daikh, David, Brinks, Ralph, Mosca, Marta, Ramsey‐Goldman, Rosalind, Smolen, Josef S, Wofsy, David, Boumpas, Dimitrios T, Kamen, Diane L, Jayne, David, Cervera, Ricard, Costedoat‐Chalumeau, Nathalie, Diamond, Betty, Gladman, Dafna D, Hahn, Bevra, Hiepe, Falk, Jacobsen, Søren, Khanna, Dinesh, Lerstrøm, Kirsten, Massarotti, Elena, McCune, Joseph, Ruiz‐Irastorza, Guillermo, Sanchez‐Guerrero, Jorge, Schneider, Matthias, Urowitz, Murray, Bertsias, George, Hoyer, Bimba F, Leuchten, Nicolai, Tani, Chiara, Tedeschi, Sara K, Touma, Zahi, Schmajuk, Gabriela, Anic, Branimir, Assan, Florence, Chan, Tak Mao, Clarke, Ann Elaine, Crow, Mary K, Czirják, László, Doria, Andrea, Graninger, Winfried, Halda‐Kiss, Bernadett, Hasni, Sarfaraz, Izmirly, Peter M, Jung, Michelle, Kumánovics, Gábor, Mariette, Xavier, Padjen, Ivan, Pego‐Reigosa, José M, Romero‐Diaz, Juanita, Fernández, Íñigo Rúa‐Figueroa, Seror, Raphaèle, Stummvoll, Georg H, Tanaka, Yoshiya, Tektonidou, Maria G, Vasconcelos, Carlos, Vital, Edward M, Wallace, Daniel J, Yavuz, Sule, Meroni, Pier Luigi, Fritzler, Marvin J, Naden, Ray, Dörner, Thomas, and Johnson, Sindhu R

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Lupus, Autoimmune Disease, Inflammatory and immune system, Adult, Antibodies, Antinuclear, Antibodies, Antiphospholipid, Autoantibodies, Cohort Studies, Complement System Proteins, Decision Support Techniques, Delphi Technique, Europe, Female, Humans, International Cooperation, Lupus Erythematosus, Systemic, Male, Middle Aged, Rheumatology, Sensitivity and Specificity, Societies, Medical, United States, Immunology, Public Health and Health Services, Arthritis & Rheumatology, Clinical sciences
Abstract

ObjectiveTo develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).MethodsThis international initiative had four phases. 1) Evaluation of antinuclear antibody (ANA) as an entry criterion through systematic review and meta-regression of the literature and criteria generation through an international Delphi exercise, an early patient cohort, and a patient survey. 2) Criteria reduction by Delphi and nominal group technique exercises. 3) Criteria definition and weighting based on criterion performance and on results of a multi-criteria decision analysis. 4) Refinement of weights and threshold scores in a new derivation cohort of 1,001 subjects and validation compared with previous criteria in a new validation cohort of 1,270 subjects.ResultsThe 2019 EULAR/ACR classification criteria for SLE include positive ANA at least once as obligatory entry criterion; followed by additive weighted criteria grouped in 7 clinical (constitutional, hematologic, neuropsychiatric, mucocutaneous, serosal, musculoskeletal, renal) and 3 immunologic (antiphospholipid antibodies, complement proteins, SLE-specific antibodies) domains, and weighted from 2 to 10. Patients accumulating ≥10 points are classified. In the validation cohort, the new criteria had a sensitivity of 96.1% and specificity of 93.4%, compared with 82.8% sensitivity and 93.4% specificity of the ACR 1997 and 96.7% sensitivity and 83.7% specificity of the Systemic Lupus International Collaborating Clinics 2012 criteria.ConclusionThese new classification criteria were developed using rigorous methodology with multidisciplinary and international input, and have excellent sensitivity and specificity. Use of ANA entry criterion, hierarchically clustered, and weighted criteria reflects current thinking about SLE and provides an improved foundation for SLE research.

Published
2019

7. Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus

Author

Schmajuk, Gabriela, Hoyer, Bimba F, Aringer, Martin, Johnson, Sindhu R, Daikh, David I, Dörner, Thomas, and panel of the initiative, the SLE classification criteria steering committee and the international SLE expert

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Health Sciences, Autoimmune Disease, Kidney Disease, Lupus, Inflammatory and immune system, Antibodies, Antinuclear, Delphi Technique, Humans, Kidney, Lupus Erythematosus, Systemic, SLE classification criteria steering committee and the international SLE expert panel of the initiative, Public Health and Health Services, Psychology, Clinical sciences, Allied health and rehabilitation science
Abstract

OBJECTIVE:The American College of Rheumatology and the European League Against Rheumatism embarked on a project to reevaluate classification criteria for systemic lupus erythematosus (SLE). The first phase of the classification project involved generation of a broad set of items potentially useful for classification of SLE and their selection for use in a subsequent forced-choice decision analysis. METHODS:A large international group of expert lupus clinicians was invited to participate in a 2-step process to generate, rate, and select items based on their importance in diagnosing early and established SLE, via a web-based survey. RESULTS:A total of 135 and 147 experts were invited to participate in the item-generation and item-reduction process, respectively. Of 145 items generated, item reduction resulted in 40 candidate items moving forward to the next phase. Key features for classifying both early and established SLE included characteristic autoantibodies, specific renal features, and skin manifestations. A small majority (51%) stated that 1 organ system would be sufficient for classifying SLE, but that additional typical laboratory features (antinuclear antibody, anti-double-stranded DNA) would be required. Notably, 85% of the expert group would positively classify SLE if renal pathology alone showed lupus nephritis. CONCLUSION:The Delphi exercise resulted in a set of 40 candidate criteria for the classification of SLE for subsequent assessment. This study comprised the largest panel ever involved in the development of SLE classification criteria, providing a broadly representative view of the current approach to classification of SLE.

Published
2018

8. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

Author

Dahou, Brahim, Rath, Eva, Piette, Yves, Devinck, Mieke, Maeyaert, Bea, Machado Ribeiro, Francinne, Euzebio Ribeiro, Sandra Lucia, Pinheiro, Marcelo, Quintana, Rosana, Gómez, Gimena, Roberts, Karen, Baez, Roberto Miguel, Castro Coello, Vanessa, Haye Salinas, María J., Maldonado, Federico Nicolas, Reyes Torres, Alvaro Andres, Alle, Gelsomina, Tanten, Romina, Maldonado Ficco, Hernán, Nieto, Romina, Gobbi, Carla, Tissera, Yohana, Pisoni, Cecilia, Paula, Alba, Albiero, Juan Alejandro, Schmid, Maria Marcela, Cosatti, Micaela, Gamba, Maria Julieta, Leandro, Carlevaris, Cusa, María Alejandra, German, Noelia, Bellomio, Veronica, Takashima, Lorena, Pera, Mariana, Cogo, Karina, Gálvez Elkin, Maria Soledad, Medina, María Alejandra, Savio, Veronica, Rojas Tessel, Ivana Romina, Perez Alamino, Rodolfo, Werner, Marina Laura, Ornella, Sofía, Casalla, Luciana, de la Vega, Maria, Severina, María, García, Mercedes, Gonzalez Lucero, Luciana, Romeo, Cecilia, Moyano, Sebastián, Barbich, Tatiana, Bertoli, Ana, Baños, Andrea, Petruzzelli, Sandra, Matellan, Carla, Conti, Silvana, Lazaro, Ma. Alicia, Rodriguez Gil, Gustavo Fabián, Risueño, Fabian, Quaglia, Maria Isabel, Scafati, Julia, Cuchiaro, Natalia Lili, Rebak, Jonathan Eliseo, Pineda, Susana Isabel, Calvo, María Elena, Picco, Eugenia, Gallino Yanzi, Josefina, Maid, Pablo, Guaglianone, Debora, Morbiducci, Julieta Silvana, Porta, Sabrina, Herscovich, Natalia, Velasco Zamora, José Luis, Kisluk, Boris, Castaños Menescardi, Maria Sol, Gallo, Rosana, Martire, María Victoria, Maldini, Carla, Goizueta, Cecilia, de la Vega Fernandez, Sabrina Solange, Aeschlimann, Carolina, Subils, Gisela, Ibáñez, Sebastián, Chassin-Trubert, Anne-Marie, Dong, Lingli, Cajas, Lui, Barešic, Marko, Anic, Branimir, Culo, Melanie-Ivana, Pavelic, Tea Ahel, Kovacevic Stranski, Kristina, Karanovic, Boris, Vencovsky, Jiri, Píchová, Marta, Filkova, Maria, Hamoud, Hesham, Vassilopoulos, Dimitrios, Guzman Melgar, Gabriela Maria, So, Ho, Király, Márta, Vojdanian, Mahdi, Balbir-Gurman, Alexandra, Abutiban, Fatemah, Zepa, Julija, Bulina, Inita, Bukauskiene, Loreta, Zaueta, Beatriz, Castillo Ortiz, Angel Alejandro, Zamora Tehozol, Erick, Vega, David, Cervántes Rosete, Diana, Martín Nares, Eduardo, Rodriguez-Reyna, Tatiana Sofia, Rull Gabayet, Marina, Alpízar-Rodríguez, Deshiré, Irazoque, Fedra, Jimenez, Xochitl, Geurts-van Bon, Lenny, Zijlstra, Theo, Hoekstra, Monique, Al-Adhoubi, Nasra, Salim, Babur, Giraldo, Enrique, Salinas, Ariel, Ugarte-Gil, Manuel, Nowakowski, Jaroslaw, Al-Emadi, Samar, Conway, Richard, Flood, Rachael, McCarthy, Geraldine, Felea, Ioana, Filipescu, Ileana, Rednic, Simona, Groseanu, Laura, Tamas, Maria Magdelena, Mlynarikova, Vanda, Skamlova, Martina, Zlnay, Martin, Miceková, Dagmar, Capova, Lubica, Macejova, Zelmira, Štenová, Emoke, Raffayova, Helena, Belakova, Gabriela, Strakova, Eva, Sencarová, Marieta, Žlnayová, Sona, Anna Sabová, Anna, Spisakova, Daniela, Oetterová, Mária, Lukacova, Olga, Bakosova, Martina, Hocevar, Alojzija, de la Torre-Rubio, Natalia, Alegre Sancho, Juan José, Corteguera Coro, Montserrat, Cobeta Garcia, Juan Carlos, Torres Martin, Maria Carmen, Campos, Jose, Gomez Puerta, Jose A, Yardimci, Gozd Kubra, Akar, Servet, Icacan, Ozan Cemal, Çelik, Selda, Vasylets, Viktoriia, Yeoh, Su-Ann, Vandevelde, Claire, Dunt, Sasha, Leeder, Jane, Macphie, Elizabeth, Salerno, Rosaria, Graver, Christine, Williams, Katie, O'Reilly, Sheila, Devine, Kirsty, Tyler, Jennifer, Warner, Elizabeth, Pilcher, James, Patel, Samir, Nikiphorou, Elena, Chadwick, Laura, Jones, Caroline Mulvaney, Harrison, Beverley, Thornton, Lucy, O'Kane, Diana, Fusi, Lucia, Low, Audrey, Horton, Sarah, Jatwani, Shraddha, Baig, Sara, Bajwa, Hammad, Berglund, Vernon, Dahle, Angela, Dorman, Walter, Hargrove, Jody, Hilton, Maren, Lebedoff, Nicholas, Leonard, Susan, Morgan, Jennifer, Pfeifer, Emily, Skemp, Archibald, Wilson, Jeffrey, Wolff, Anne, Cepeda, Eduardo, D'Silva, Kristin, Hsu, Tiffany, Patel, Naomi, Sparks, Jeffrey, Todd, Derrick, Wallace, Zachary, Hare, Denise, Calabrese, Cassandra, Adams, Christopher, Khosroshahi, Arezou, Kilian, Adam, White, Douglas, Winter, Melanie, Fields, Theodore, Siegel, Caroline, Daver, Nicole, Harvey, Melissa, Kramer, Neil, Lamore, Concetta, Hogarty, Suneya, Yeter, Karen, Wise, Leanna, Siddique, Faizah, Ban, Byung, Tanner, Tamar, Ruderman, Eric, Davis, William, Quinet, Robert, Scopelitis, Evangeline, Toribio Toribio, Karen, Webb-Detiege, Tameka, Zakem, Jerald, Abbass, Khurram, Kepecs, Gilbert, Miranda, Lilliam, Guma, Michael, Haikal, Ammar, Mody, Sushama, Mueller, Daric, Jayatilleke, Arundathi, Zell, JoAnn, Bays, Alison, Dao, Kathryn, Fatemeh, Ezzati, Parks, Deborah, Karp, David, Quiceno, Guillermo, Sattui, Sebastian E, Putman, Michael S, Seet, Andrea M, Gianfrancesco, Milena A, Beins, Kaley, Hill, Catherine, Liew, David, Mackie, Sarah L, Mehta, Puja, Neill, Lorna, Gomez, Gimena, Salinas, Maria Isabel Haye, Mariz, Henrique Ataide, de Sousa Studart, Samia Araujo, Araujo, Nafice Costa, Knight, Ann, Rozza, Davide, Quartuccio, Luca, Samson, Maxime, Bally, Stéphane, Maria, Alexandre TJ, Chazerain, Pascal, Hasseli, Rebecca, Müller-Ladner, Ulf, Hoyer, Bimba F, Voll, Reinhard, Torres, Rita Pinheiro, Luis, Mariana, Ribeirio, Sandra Lucia Euzebio, Sparks, Jeffrey A, Hsu, Tiffany Y-T, D’Silva, Kristin M, Patel, Naomi J, Gilbert, Emily, Almada, Maria Valenzuela, Duarte-García, Alí, Jacobsohn, Lindsay, Izadi, Zara, Strangfeld, Anja, Mateus, Elsa F, Hyrich, Kimme L, Gossec, Laure, Carmona, Loreto, Lawson-Tovey, Saskia, Kearsley-Fleet, Lianne, Schaefer, Martin, Sirotich, Emily, Hausmann, Jonathan S, Sufka, Paul, Bhana, Suleman, Liew, Jean W, Grainger, Rebecca, Machado, Pedro M, Wallace, Zachary S, Yazdany, Jinoos, and Robinson, Philip C

Published
2021
Full Text
View/download PDF

10. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

Author

Robinson, Philip C., Bhana, Suleman, Liew, Jean W., Sufka, Paul H., Singh, Namrata, Howard, Richard A., Kim, Alfred H.J., Westrich-Robertson, Tiffany, Sirotich, Emily, Tsui, Edmund, Duarte-Garcia, Ali, Sparks, Jeffrey A., Tam, Herman, Jayatilleke, Arundathi, Konig, Maximilian F., Graef, Elizabeth R., Putman, Michael S., Syed, Reema H., Korsten, Peter, Mateus, Elsa, Sattui, Sebastian E., Wallace, Zachary S., Laura, Upton A., Adam, Kilian, Chock, Yu Pei Eugenia, White, Douglas W., Zamora, Geraldine T., Traboco, Lisa S., Patel, Aarat M., Grainger, Rebecca, Ugarte-Gil, Manuel F., Gianfrancesco, Milena A., Amigues, Isabelle, Sanchez-Alvarez, Catalina, Trupin, Laura, Jacobsohn, Lindsay R., Beesley, Richard P., Hoyer, Bimba F., Machado, Pedro M., Makan, Kavita, Gossec, Laure, Priyank, Chaudhary, Leipe, Jan, Wallace, Beth, Angeles-Han, Sheila T., Almaghlouth, Ibrahim A., Katherine, Wysham D., Padula, Anthony S., Berenbaum, Francis, Treemarcki, Erin M., Sinha, Rashmi, Lewandowski, Laura B., Webb, Kate, Young, Kristen J., Bulina, Inita, Herrera Uribe, Sebastian, Rubinstein, Tamar B., Nolan, Marc W., Ang, Elizabeth Y., Venuturupalli, Swamy R., Hausmann, Jonathan S., Dubreuil, Maureen, Pisoni, Cecilia N., Cosatti, Micaela A., Campos, Jose, Simard, Julia F., Conway, Richard, Peterson, Tiffany M., Harrison, Carly O., Felix, Christele, Richards, Dawn P., Proulx, Laurie, Akpabio, Akpabio A., Worthing, Angus B., Laidlaw, Lynn R., Reid, Pankti, Palmerlee, Candace A., Danila, Maria I., Sahar, Lotfi-Emran, Linh, Ngo Q., Agarwal, Arnav, Studenic, Paul, Liew, David F.L., Larche, Maggie J., Mingolla, Serena A.M., Zamora, Erick A., Angevare, Saskya S., Sinha, Rashmi R., Durrant, Karen L.W., Peirce, Andrea, Somers, Emily C., Cappelli, Laura C., Frankel, Brittany A., Kumar, Bharat, Silinsky Krupnikova, Sonia D., Rosario Vega, Jorge A., Frankovich, Jourdan, Fernandez-Ruiz, Ruth, Posada Velásquez, Marcela, Yeoh, Su-Ann, Marino, Maria, Nudel, Michal, Scott, Chrisiaan, Rodríguez, Cecilia, Martín Mancheño, Ana I., Seo, Philip, Gamboa-Cárdenas, Rocío V., Pimentel-Quiroz, Victor R., Reátegui-Sokolova, Cristina, Kihara, Mari, Lin, Chung M.A., Kattula, Dheera, Laila, Girgis, Carmona, Loreto, Wallace, John, Yazdany, Jinoos, Costello, Wendy, Gore-massy, Monique C., Tomasella, Laura-Ann, Kodek, Moré A., Hausmann, Jonathan S, Kennedy, Kevin, Simard, Julia F, Liew, Jean W, Sparks, Jeffrey A, Moni, Tarin T, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Sattui, Sebastian E, Semalulu, Teresa, Foster, Gary, Surangiwala, Salman, Thabane, Lehana, Beesley, Richard P, Durrant, Karen L, Mateus, Elsa F, Mingolla, Serena, Palmerlee, Candace A, Richards, Dawn P, Liew, David F L, Hill, Catherine L, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, and Wallace, Zachary S

Published
2021
Full Text
View/download PDF

11. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

Author

Banovich, Nicholas E., Desai, Tushar, Eickelberg, Oliver, Haniffa, Muzlifa, Horvath, Peter, Kropski, Jonathan A., Lafyatis, Robert, Lundeberg, Joakim, Meyer, Kerstin, Nawijn, Martijn C., Nikolic, Marko, Ordovas Montanes, Jose, Pe’er, Dana, Tata, Purushothama Rao, Rawlins, Emma, Regev, Aviv, Reyfman, Paul, Samakovlis, Christos, Schultze, Joachim, Shalek, Alex, Shepherd, Douglas, Spence, Jason, Teichmann, Sarah, Theis, Fabian, Tsankov, Alexander, van den Berge, Maarten, von Papen, Michael, Whitsett, Jeffrey, Zaragosi, Laure Emmanuelle, Angelov, Angel, Bals, Robert, Bartholomäus, Alexander, Becker, Anke, Bezdan, Daniela, Bonifacio, Ezio, Bork, Peer, Clavel, Thomas, Colme-Tatche, Maria, Diefenbach, Andreas, Dilthey, Alexander, Fischer, Nicole, Förstner, Konrad, Frick, Julia-Stefanie, Gagneur, Julien, Goesmann, Alexander, Hain, Torsten, Hummel, Michael, Janssen, Stefan, Kalinowski, Jörn, Kallies, René, Kehr, Birte, Keller, Andreas, Kim-Hellmuth, Sarah, Klein, Christoph, Kohlbacher, Oliver, Korbel, Jan O., Kurth, Ingo, Landthaler, Markus, Li, Yang, Ludwig, Kerstin, Makarewicz, Oliwia, Marz, Manja, McHardy, Alice, Mertes, Christian, Nöthen, Markus, Nürnberg, Peter, Ohler, Uwe, Ossowski, Stephan, Overmann, Jörg, Peter, Silke, Pfeffer, Klaus, Poetsch, Anna R., Pühler, Alfred, Rajewsky, Niklaus, Ralser, Markus, Rieß, Olaf, Ripke, Stephan, Nunes da Rocha, Ulisses, Rosenstiel, Philip, Saliba, Antoine-Emmanuel, Sander, Leif Erik, Sawitzki, Birgit, Schiffer, Philipp, Schulte, Eva-Christina, Schultze, Joachim L., Sczyrba, Alexander, Stegle, Oliver, Stoye, Jens, Vehreschild, Janne, Vogel, Jörg, von Kleist, Max, Walker, Andreas, Walter, Jörn, Wieczorek, Dagmar, Ziebuhr, John, Bernardes, Joana P., Mishra, Neha, Tran, Florian, Bahmer, Thomas, Best, Lena, Blase, Johanna I., Bordoni, Dora, Franzenburg, Jeanette, Geisen, Ulf, Josephs-Spaulding, Jonathan, Köhler, Philipp, Künstner, Axel, Rosati, Elisa, Aschenbrenner, Anna C., Bacher, Petra, Baran, Nathan, Boysen, Teide, Brandt, Burkhard, Bruse, Niklas, Dörr, Jonathan, Dräger, Andreas, Elke, Gunnar, Ellinghaus, David, Fischer, Julia, Forster, Michael, Franke, Andre, Franzenburg, Sören, Frey, Norbert, Friedrichs, Anette, Fuß, Janina, Glück, Andreas, Hamm, Jacob, Hinrichsen, Finn, Hoeppner, Marc P., Imm, Simon, Junker, Ralf, Kaiser, Sina, Kan, Ying H., Knoll, Rainer, Lange, Christoph, Laue, Georg, Lier, Clemens, Lindner, Matthias, Marinos, Georgios, Markewitz, Robert, Nattermann, Jacob, Noth, Rainer, Pickkers, Peter, Rabe, Klaus F., Renz, Alina, Röcken, Christoph, Rupp, Jan, Schaffarzyk, Annika, Scheffold, Alexander, Schulte-Schrepping, Jonas, Schunk, Domagoj, Skowasch, Dirk, Ulas, Thomas, Wandinger, Klaus-Peter, Wittig, Michael, Zimmermann, Johannes, Busch, Hauke, Hoyer, Bimba F., Kaleta, Christoph, Heyckendorf, Jan, Kox, Matthijs, Rybniker, Jan, and Schreiber, Stefan

Published
2020
Full Text
View/download PDF

12. The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population—A comparison of two German registries

Author

Hasseli, Rebecca, primary, Hanses, Frank, additional, Stecher, Melanie, additional, Specker, Christof, additional, Weise, Tobias, additional, Borgmann, Stefan, additional, Hasselberger, Martina, additional, Hertenstein, Bernd, additional, Hower, Martin, additional, Hoyer, Bimba F., additional, Koll, Carolin, additional, Krause, Andreas, additional, von Lilienfeld-Toal, Marie, additional, Lorenz, Hanns-Martin, additional, Merle, Uta, additional, Nunes de Miranda, Susana M., additional, Pletz, Mathias W., additional, Regierer, Anne C., additional, Richter, Jutta G., additional, Rieg, Siegbert, additional, Roemmele, Christoph, additional, Ruethrich, Maria M., additional, Schmeiser, Tim, additional, Schulze-Koops, Hendrik, additional, Strangfeld, Anja, additional, Vehreschild, Maria J.G.T., additional, Voit, Florian, additional, Voll, Reinhard E., additional, Vehreschild, Jörg Janne, additional, Müller-Ladner, Ulf, additional, and Pfeil, Alexander, additional

Published
2024
Full Text
View/download PDF

14. The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis

Author

Iking-Konert, Christof, Wallmeier, Pia, Arnold, Sabrina, Adler, Sabine, de Groot, Kirsten, Hellmich, Bernhard, Hoyer, Bimba F., Holl-Ulrich, Konstanze, Ihorst, Gabriele, Kaufmann, Margit, Kötter, Ina, Müller-Ladner, Ulf, Magnus, T., Rech, Jürgen, Schubach, Fabian, Schulze-Koops, Hendrik, Venhoff, Nils, Wiech, Thorsten, Villiger, Peter, and Lamprecht, Peter

Published
2021
Full Text
View/download PDF

15. Limited antibody response after BA.4‐5 adapted booster vaccination in rheumatic patients receiving anti‐TNF therapy: Results of a case series

Author

Geisen, Ulf M., primary, Voß, Mathias, additional, Rose, Ruben, additional, Neumann, Franziska, additional, Bäumler, Carina, additional, Müller, Sina, additional, Paltzow, Lea, additional, Christophersen, Christina M., additional, Münier, Merle, additional, Hildebrand, Elena, additional, Hoff, Paula, additional, Longardt, Ann C., additional, Lorentz, Thomas, additional, Schirmer, Jan H., additional, Sümbül, Melike, additional, Tran, Florian, additional, Berner, Dennis, additional, Fickenscher, Helmut, additional, Gerdes, Sascha, additional, Schreiber, Stefan, additional, Krumbholz, Andi, additional, and Hoyer, Bimba F., additional

Published
2023
Full Text
View/download PDF

18. Chronische Entzündungserkrankungen in Deutschland

Author

Leipe, Jan, primary, Schmelz, Renate, additional, Riemekasten, Gabriela, additional, Thaçi, Diamant, additional, Henes, Jörg, additional, Schäkel, Knut, additional, Pinter, Andreas, additional, Sticherling, Michael, additional, Wegner, Joanna, additional, Fusco, Stefano, additional, Linke, Miriam, additional, Weber, Valeria, additional, Manz, Karina C., additional, Bartz, Holger, additional, Roecken, Marit, additional, Schmidt, Sandra, additional, and Hoyer, Bimba F., additional

Published
2023
Full Text
View/download PDF

19. Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

Author

Tran, Florian, primary, Harris, Danielle M.M., additional, Scharmacher, Alena, additional, Graßhoff, Hanna, additional, Sterner, Kristina, additional, Schinke, Susanne, additional, Käding, Nadja, additional, Humrich, Jens Y., additional, Cabral-Marques, Otávio, additional, Bernardes, Joana P., additional, Mishra, Neha, additional, Bahmer, Thomas, additional, Franzenburg, Jeanette, additional, Hoyer, Bimba F., additional, Glück, Andreas, additional, Guggeis, Martina, additional, Ossysek, Alexander, additional, Küller, Andre, additional, Frank, Derk, additional, Lange, Christoph, additional, Rupp, Jan, additional, Heyckendorf, Jan, additional, Gaede, Karoline I., additional, Amital, Howard, additional, Rosenstiel, Philip, additional, Shoenfeld, Yehuda, additional, Halpert, Gilad, additional, Rosenberg, Avi Z., additional, Schulze-Forster, Kai, additional, Heidecke, Harald, additional, Riemekasten, Gabriela, additional, and Schreiber, Stefan, additional

Published
2022
Full Text
View/download PDF

20. Verträglichkeit und Sicherheit von COVID-19-Impfstoffen nach Erstimpfung bei Patienten mit rheumatischen Erkrankungen

Author

Hasseli, Rebecca, Hoyer, Bimba F., Lorenz, Hanns-Martin, Pfeil, Alexander, Regierer, Anne, Richter, Jutta G., Schmeiser, Tim, Strangfeld, Anja, Voll, Reinhard, Krause, Andreas, Specker, Christof, Müller-Ladner, Ulf, and Schulze-Koops, Hendrik

Subjects
Medicine and health
Abstract

Einleitung: Zu Beginn der Impfkampagne herrschte Ungewissheit bezüglich der Verträglichkeit und Sicherheit der neuartigen Impfstoffe gegen SARS-CoV-2 bei Patienten mit rheumatischen Erkrankungen (RE) mit und ohne Immunmodulation. Es lagen insbesondere keine Daten bezüglich der Verträglichkeit [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2022
Full Text
View/download PDF

21. Durchbruchinfektionen bei vollständig geimpften Patienten mit entzündlich-rheumatischen Erkrankungen – Daten aus dem COVID19-Rheuma.de-Register

Author

Hasseli, Rebecca, Hoyer, Bimba F., Huppke, Liam, Lorenz, Hanns-Martin, Pfeil, Alexander, Regierer, Anne, Richter, Jutta, Schmeiser, Tim, Strangfeld, Anja, Voll, Reinhard, Krause, Andreas, Schulze-Koops, Hendrik, Specker, Christof, and Müller-Ladner, Ulf

Subjects
Medicine and health
Abstract

Einleitung: COVID-19-Impfungen reduzieren nachweislich das Risiko für schwere Verläufe einer SARS-CoV-2-Infektion. Auch bei Patienten mit entzündlich-rheumatischen Erkrankungen (ERE) und bei Patienten unter Immunmodulation konnte mehrheitlich eine ausreichende humorale Immunantwort auf [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2022
Full Text
View/download PDF

22. Analyse von intestinalem Mikrobiom und Ernährungsgewohnheiten bei Patienten mit Rheumatoider Arthritis

Author

Schirmer, Jan, Schlicht, Kristina, Knappe, Carina, Türk, Kathrin, Schulte, Dominik Maria, Hartmann, Katharina, Settgast, Ute, Franke, Andre, Schreiber, Stefan, Hoyer, Bimba F., and Laudes, Matthias

Subjects
Medicine and health
Abstract

Einleitung: Der Einfluss sowohl des intestinalen Mikrobioms, als auch von Umweltfaktoren, wie den Ernährungsgewohnheiten auf zahlreiche metabolische Erkrankungen, wie Adipositas und Typ 2 Diabetes mellitus ist klar etabliert. In den letzten Jahren sind zunehmend Veränderungen des intestinalen [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2022
Full Text
View/download PDF

23. Zeitliche Trends im Verlauf von SARS-CoV-2-Infektionen seit Beginn des COVID19-Rheuma.de-Registers

Author

Hasseli, Rebecca, Hoyer, Bimba F., Lorenz, Hanns-Martin, Pfeil, Alexander, Regierer, Anne, Richter, Jutta, Schmeiser, Tim, Strangfeld, Anja, Voll, Reinhard, Krause, Andreas, Schulze-Koops, Hendrik, Müller-Ladner, Ulf, and Specker, Christof

Subjects
Medicine and health
Abstract

Einleitung: Seit Beginn der Pandemie haben Virusmutationen, Zulassung von Impfstoffen, Medikamente zur Therapie von COVID-19 sowie der fortschreitende Informationsgewinn zum Umgang mit dem Coronavirus Einfluss auf den Verlauf der Pandemie genommen. Zur Frage, inwieweit sich die klinischen Verläufe [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2022
Full Text
View/download PDF

24. Das Gemeinsame Vaskulitis-Register im deutschsprachigen Raum (GeVas) – eine Subgruppenanalyse der 131 RZA-Patienten

Author

Wallmeier, Pia, Arnold, Sabrina, Schubach, Fabian, Ihorst, Gabriele, Dörnbrack, Katharinia, Aries, Peer Malte, Bergner, Raoul, Bremer, Jan Philip, Görl, Norman, Hellmich, Bernhard, Henes, Jörg, Hoyer, Bimba F., Kangowski, Antje, Kötter, Ina, Metzler, Claudia, Müller-Ladner, Ulf, Schaier, Matthias, Schönermark, Ulf, Thiel, Jens, Unger, Leonore, Venhoff, Nils, Weinmann-Menke, Julia, Petersen, Jana, Lamprecht, Peter, and Iking-Konert, Christof

Subjects
Medicine and health
Abstract

Einleitung: Die am häufigsten diagnostizierte Vaskulitis in Deutschland ist die Riesenzellarteriitis (RZA), mit einer Inzidenz von ca. 3,5 pro 100.000 Personen bei Patienten über 50 Jahren, mit steigendem Alter noch häufiger. Wie die meisten Vaskulitiden ist auch die RZA durch chronische [zum vollständigen Text gelangen Sie über die oben angegebene URL]

Published
2022
Full Text
View/download PDF

27. COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

Author

Putman, Michael, Kennedy, Kevin, Sirotich, Emily, Liew, Jean W, Sattui, Sebastian E, Moni, Tarin T, Akpabio, Akpabio A, Alpizar-Rodriguez, Deshire, Angevare, Saskya, Beesley, Richard P, Berenbaum, Francis, Bulina, Inita, Chock, Yu Pei Eugenia, Conway, Richard, Duarte-García, Ali, Singh, Aman Dev, Duff, Eimear, Durrant, Karen L, Gheita, Tamer A, Hill, Catherine L, Howard, Richard, Hoyer, Bimba F, Hsieh, Evelyn, el Kibbi, Lina, Kilian, Adam, Kim, Alfred H J, Liew, David F L, Lo, Chieh, Mateus, Elsa F, Miller, Bruce, Mingolla, Serena, Nudel, Michal, Singh, Jasvinder A, Singh, Namrata, Ugarte-Gil, Manuel F, Wallace, John, Young, Kristen J, Zamora-Tehozol, Erick Adrian, Bhana, Suleman, Costello, Wendy, Grainger, Rebecca, Machado, Pedro M, Robinson, Philip C, Sufka, Paul, Wallace, Zachary S, Yazdany, Jinoos, Harrison, Carly, Larché, Maggie J, Levine, Mitchell, Foster, Gary, Thabane, Lehana, Hausmann, Jonathan S, Sparks, Jeffrey A, and Simard, Julia F

Published
2022
Full Text
View/download PDF

28. Organ-Specific Self-Assessment (OSSA): Ein Fragebogen zur Patienten-basierten Beschreibung des Gesundheitszustandes bei multisystemischen Entzündungserkrankungen

Author

Zeuner, Rainald, Hübenthal, Matthias, Schrinner, Florian, Schreiber, Stefan, Hoyer, Bimba F., and Franke, Andre

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Rheumatologische Erkrankungen und andere systemische Entzündungserkrankungen (wie Psoriasis oder chronisch entzündlicher Darmerkrankungen) manifestieren sich häufig an verschiedenen Organsystemen. Eine bestmögliche Behandlung erfordert daher eine diagnostische und therapeutische[zum vollständigen Text gelangen Sie über die oben angegebene URL], Deutscher Rheumatologiekongress 2021, 49. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 35. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)

Published
2021
Full Text
View/download PDF

29. Outcome of SARS-CoV-2 infection in patients with rheumatoid arthritis under treatment with Janus kinase inhibitors compared to etanercept

Author

Hasseli, Rebecca, Hoyer, Bimba F., Krause, Andreas, Lorenz, Hanns-Martin, Pfeil, Alexander, Regierer, Anne, Richter, Jutta, Schmeiser, Tim, Strangfeld, Anja, Schulze-Koops, Hendrik, Voll, Reinhard, Specker, Christof, and Müller-Ladner, Ulf

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Introduction: Various immunosuppressants have been used as anti-inflammatory drugs and cytokine inhibitors to treat the complications of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) disease 2019 (COVID-19). Of these, there has been particular interest in the Janus kinase (JAK) inhibitors[for full text, please go to the a.m. URL], Deutscher Rheumatologiekongress 2021, 49. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 35. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh), Wissenschaftliche Herbsttagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR)

Published
2021
Full Text
View/download PDF

30. Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies

Author

Geisen, Ulf M, primary, Sümbül, Melike, additional, Tran, Florian, additional, Berner, Dennis K, additional, Reid, Hayley M, additional, Vullriede, Lena, additional, Ciripoi, Maria, additional, Longardt, Ann C, additional, Hoff, Paula, additional, Morrison, Peter J, additional, Schneider, Verena E, additional, Zeuner, Rainald, additional, Schirmer, Jan H, additional, Steinbach, Andrea, additional, Nikolaus, Susanna, additional, Gerdes, S, additional, Schreiber, Stefan, additional, Bacher, Petra, additional, and Hoyer, Bimba F, additional

Published
2021
Full Text
View/download PDF

31. The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Author

Alexander, Tobias, Sarfert, Ramona, Klotsche, Jens, Kühl, Anja A, Rubbert-Roth, Andrea, Lorenz, Hannes-Martin, Rech, Jürgen, Hoyer, Bimba F, Cheng, Qingyu, Waka, Aderajew, Taddeo, Adriano, Wiesener, Michael, Schett, Georg, Burmester, Gerd-Rüdiger, Radbruch, Andreas, Hiepe, Falk, and Voll, Reinhard E

Published
2015
Full Text
View/download PDF

32. TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

Author

Regierer, Anne Constanze, primary, Hasseli, Rebecca, additional, Schäfer, Martin, additional, Hoyer, Bimba F, additional, Krause, Andreas, additional, Lorenz, Hanns-Martin, additional, Pfeil, Alexander, additional, Richter, Jutta, additional, Schmeiser, Tim, additional, Schulze-Koops, Hendrik, additional, Strangfeld, Anja, additional, Voll, Reinhard E, additional, Specker, Christof, additional, and Mueller-Ladner, Ulf, additional

Published
2021
Full Text
View/download PDF

33. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?

Author

Hasseli, Rebecca, Pfeil, Alexander, Hoyer, Bimba F., Krause, Andreas, Lorenz, Hanns-Martin, Richter, Jutta G., Schmeiser, Tim, Voll, Reinhard E., Schulze-Koops, Hendrik, Specker, Christof, and Müller-Ladner, Ulf

Subjects
Arthritis, Rheumatoid, Rheumatology, SARS-CoV-2, Immunology, Arthritis, Psoriatic, Spondylarthritis, Medizin, Immunology and Allergy, COVID-19, Humans, Middle Aged
Abstract

Rheumatoid arthritis (RA) and spondyloarthritis (SpA) are the most common inflammatory rheumatic diseases (IRD). The aim of this study was to elucidate differences in the outcome of SARS-CoV-2 infection in RA- and SpA-patients.Data from the German COVID-19 registry for IRD patients from 30th March to 16th November 2020 were analysed. 208 RA and SpA patients were included in the study, matched for gender and age.104 SpA patients (40% patients with ankylosing spondylitis, 54% with psoriatic arthritis and 6% with enteropathic arthritis) were compared to 104 RA patients. For both groups, median age was 56 years. TNF-i treatment was reported in 45% of the SpA and in 19% of RA patients (p=0.001). Glucocorticoids were used in 13% of the SpA and in 40% of the RA patients (p=0.001). In both groups, the majority of the patients (97% SpA, 95% RA) recovered from COVID-19. Hospitalisation was needed in 16% of the SpA and in 30% of the RA patients (p=0.05), and oxygen treatment in 10% and 18% respectively (p=ns). Three versus six (p=ns) fatal courses were reported in the SpA versus the RA group.The study revealed that the hospitalisation rate during COVID-19 infection, but not the mortality, was significantly higher in RA as compared to SpA patients. This could be explained either by different treatment strategies or by different susceptibilities of the two diseases.

Published
2020

34. Mukosale B-Zellen im peripheren Blut von Patienten mit Granulomatose mit Polyangiitis als Biomarker für mukosale Organaffektionen?

Author

Schaffarzyk, Annika, Geisen, Ulf, Dörr, Jonathan, Kaiser, Sina, Reid, Hayley, Laudien, Martin, and Hoyer, Bimba F.

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Die Granulomatose mit Polyangiitis (GPA) ist eine Vaskulitis der kleinen und mittleren Gefäße, die sich im lokalisierten Erststadium zunächst als Entzündung im oberen Respirationstrakt zeigt. B-Zellen spielen in der Pathogenese eine Rolle, indem sie Autoantikörper[zum vollständigen Text gelangen Sie über die oben angegebene URL], Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh)

Published
2020

35. Statusbericht des GeVas Registers: Gemeinsames Vaskulitis Register im deutschsprachigen Raum zur prospektiven Auswertung des Langzeitverlaufs von Vaskulitis-Patienten

Author

Wallmeier, Pia, Iking-Konert, Christof, Adler, Sabine, De Groot, Kirsten, Hellmich, Bernhard, Hoyer, Bimba F., Ihorst, Gabriele, Kaufmann, Magrit, Magnus, Tim, Müller-Ladner, Ulf, Rech, Jürgen, Schulze-Koops, Hendrik, Venhoff, Nils, Villiger, Peter, Schubach, Fabian, and Lamprecht, Peter

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Ziel des Gemeinsamen Vaskulitis Registers im deutschsprachigen Raum (GeVas) ist es, alle Patienten mit einer neu diagnostizierten Vaskulitis oder einer Therapieumstellung bei einem Rezidiv in einem prospektiven, multizentrischen und pseudonymisierten Register zu erfassen und so den Langzeitverlauf[zum vollständigen Text gelangen Sie über die oben angegebene URL], Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh)

Published
2020

36. Alter, Komorbiditäten und Therapie mit Glukokortikoiden sind Risikofaktoren für eine COVID-19-bedingte Hospitalisierung: erste Ergebnisse aus dem deutschen COVID-19-Rheuma-Register

Author

Regierer, Anne, Hasseli, Rebecca, Müller-Ladner, Ulf, Hoyer, Bimba F., Krause, Andreas, Lorenz, Hanns-Martin, Pfeil, Alexander, Richter, Jutta, Schmeiser, Tim, Schulze-Koops, Hendrik, Strangfeld, Anja, Voll, Reinhard, and Specker, Christof

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Für Patienten mit entzündlich-rheumatischen Erkrankungen (ERE) und ihre behandelnden Ärzte stellt die SARS-CoV-2-Pandemie eine besondere Herausforderung dar. Weder ist bisher ausreichend bekannt, ob ein erhöhtes Infektionsrisiko besteht noch ob die Patienten ein erhöhtes[zum vollständigen Text gelangen Sie über die oben angegebene URL], Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh)

Published
2020
Full Text
View/download PDF

37. Untersuchung des psychosozialen Einflusses der Corona-Pandemie auf rheumatologische Patienten in einer prospektiven, longitudinalen Befragung

Author

Hasseli, Rebecca, Schmeiser, Tim, Hermann, Christiane, Kappesser, Judith, Pfeiffer, Silas, Müller-Ladner, Ulf, Richter, Jutta, Regierer, Anne, Voll, Reinhard, Lorenz, Hanns-Martin, Strangfeld, Anja, Krause, Andreas, Pfeil, Alexander, Schulze-Koops, Hendrik, Specker, Christof, and Hoyer, Bimba F.

Subjects
ddc: 610, 610 Medical sciences, Medicine
Abstract

Einleitung: Die Gesamtsituation „Corona-Pandemie“ stellt weltweit die Bevölkerung vor große Herausforderungen. Die Erfahrung der Kontaktbeschränkungen, möglicherweise behördlich angeordnete Quarantänen aber auch die Angst vor einer möglichen Ansteckung[zum vollständigen Text gelangen Sie über die oben angegebene URL], Deutscher Rheumatologiekongress 2020, 48. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), 34. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh)

Published
2020

38. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry : a retrospective cohort study

Author

Sattui, Sebastian E., Conway, Richard, Putman, Michael S., Seet, Andrea M., Gianfrancesco, Milena A., Beins, Kaley, Hill, Catherine, Liew, David, Mackie, Sarah L., Mehta, Puja, Neill, Lorna, Gomez, Gimena, Salinas, Maria Isabel Haye, Maldonado, Federico Nicolas, Mariz, Henrique Ataide, Studart, Samia Araujo de Sousa, Araujo, Nafice Costa, Knight, Ann, Rozza, Davide, Quartuccio, Luca, Samson, Maxime, Bally, Stephane, Maria, Alexandre T. J., Chazerain, Pascal, Hasseli, Rebecca, Muller-Ladner, Ulf, Hoyer, Bimba F., Voll, Reinhard, Torres, Rita Pinheiro, Luis, Mariana, Ribeirio, Sandra Lucia Euzebio, Al-Emadi, Samar, Sparks, Jeffrey A., Hsu, Tiffany Y-T, D'Silva, Kristin M., Patel, Naomi J., Wise, Leanna, Gilbert, Emily, Almada, Maria Valenzuela, Duarte-Garcia, Ali, Ugarte-Gil, Manuel, Jacobsohn, Lindsay, Izadi, Zara, Strangfeld, Anja, Mateus, Elsa F., Hyrich, Kimme L., Gossec, Laure, Carmona, Loreto, Lawson-Tovey, Saskia, Kearsley-Fleet, Lianne, Schaefer, Martin, Sirotich, Emily, Hausmann, Jonathan S., Sufka, Paul, Bhana, Suleman, Liew, Jean W., Grainger, Rebecca, Machado, Pedro M., Wallace, Zachary S., Yazdany, Jinoos, Robinson, Philip C., Sattui, Sebastian E., Conway, Richard, Putman, Michael S., Seet, Andrea M., Gianfrancesco, Milena A., Beins, Kaley, Hill, Catherine, Liew, David, Mackie, Sarah L., Mehta, Puja, Neill, Lorna, Gomez, Gimena, Salinas, Maria Isabel Haye, Maldonado, Federico Nicolas, Mariz, Henrique Ataide, Studart, Samia Araujo de Sousa, Araujo, Nafice Costa, Knight, Ann, Rozza, Davide, Quartuccio, Luca, Samson, Maxime, Bally, Stephane, Maria, Alexandre T. J., Chazerain, Pascal, Hasseli, Rebecca, Muller-Ladner, Ulf, Hoyer, Bimba F., Voll, Reinhard, Torres, Rita Pinheiro, Luis, Mariana, Ribeirio, Sandra Lucia Euzebio, Al-Emadi, Samar, Sparks, Jeffrey A., Hsu, Tiffany Y-T, D'Silva, Kristin M., Patel, Naomi J., Wise, Leanna, Gilbert, Emily, Almada, Maria Valenzuela, Duarte-Garcia, Ali, Ugarte-Gil, Manuel, Jacobsohn, Lindsay, Izadi, Zara, Strangfeld, Anja, Mateus, Elsa F., Hyrich, Kimme L., Gossec, Laure, Carmona, Loreto, Lawson-Tovey, Saskia, Kearsley-Fleet, Lianne, Schaefer, Martin, Sirotich, Emily, Hausmann, Jonathan S., Sufka, Paul, Bhana, Suleman, Liew, Jean W., Grainger, Rebecca, Machado, Pedro M., Wallace, Zachary S., Yazdany, Jinoos, and Robinson, Philip C.

Abstract

Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ damage cause by primary systemic vasculitis, and the demographic factors associated with these conditions. We therefore aimed to investigate factors associated with COVID-19 outcomes in patients with primary systemic vasculitis or polymyalgia rheumatica. Methods In this retrospective cohort study, adult patients (aged >= 18 years) diagnosed with COVID-19 between March 12, 2020, and April 12, 2021, who had a history of primary systemic vasculitis (antineutrophil cytoplasmic antibody [ANCA]-associated vasculitis, giant cell arteritis, Behcet's syndrome, or other vasculitis) or polymyalgia rheumatica, and were reported to the COVID-19 Global Rheumatology Alliance registry were included. To assess COVID-19 outcomes in patients, we used an ordinal COVID-19 severity scale, defined as: (1) no hospitalisation; (2) hospitalisation without supplemental oxygen; (3) hospitalisation with any supplemental oxygen or ventilation; or (4) death. Multivariable ordinal logistic regression analyses were used to estimate odds ratios (ORs), adjusting for age, sex, time period, number of comorbidities, smoking status, obesity, glucocorticoid use, disease activity, region, and medication category. Analyses were also stratified by type of rheumatic disease. Findings Of 1202 eligible patients identified in the registry, 733 (61.0%) were women arid 469 (39.0%) were men, and their mean age was 63.8 years (SD 17.1). A total of 374 (31.1%) patients had polymyalgia rheumatica, 353 (29.4%) had ANCA-associated vasculitis, 183 (15.2%) had giant cell arteritis, 112 (9.3%) had Behcet's syndrome, and 180 (15.0%) had other vasculitis. Of 1020 (84. 9%) patients with outcome data, 512 (S0.2%) were not hospitalised, 114 (11.2%) were hospitalised and did not receive supplemental oxygen, 239 (23 - 4%) were hospitalised and received

Published
2021
Full Text
View/download PDF

39. European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

Author

Aringer, Martin, Brinks, Ralph, Dörner, Thomas, Daikh, David, Mosca, Marta, Ramsey-Goldman, Rosalind, Smolen, Josef S., Wofsy, David, Boumpas, Dimitrios T., Kamen, Diane L., Jayne, David, Cervera, R., Costedoat-Chalumeau, Nathalie, Diamond, Betty, Gladman, Dafna D., Hahn, Bevra, Hiepe, Falk, Jacobsen, Søren, Khanna, Dinesh, Lerstrøm, Kirsten, Massarotti, Elena, McCune, Joseph, Ruiz-Irastorza, Guillermo, Sanchez-Guerrero, Jorge, Schneider, Matthias, Urowitz, Murray, Bertsias, George, Hoyer, Bimba F., Leuchten, Nicolai, Schmajuk, Gabriela, Tani, Chiara, Tedeschi, Sara K., Touma, Zahi, Anic, Branimir, Assan, Florence, Chan, Tak Mao, Clarke, Ann Elaine, Crow, Mary K., Czirják, László, Doria, Andrea, Graninger, Winfried, Halda-Kiss, Bernadett, Hasni, Sarfaraz, Izmirly, Peter M., Jung, Michelle, Kumánovics, Gábor, Mariette, Xavier, Padjen, Ivan, Pego-Reigosa, José M., Romero-Diaz, Juanita, Rúa-Figueroa, Íñigo, Seror, Raphaèle, Stummvoll, Georg H., Tanaka, Yoshiya, Tektonidou, Maria G., Vasconcelos, Carlos, Vital, Edward M., Wallace, Daniel J., Yavuz, Sule, Meroni, Pier Luigi, Fritzler, Marvin J., Naden, Ray, Costenbader, Karen, Johnson, Sindhu R., Aringer, Martin, Brinks, Ralph, Dörner, Thomas, Daikh, David, Mosca, Marta, Ramsey-Goldman, Rosalind, Smolen, Josef S., Wofsy, David, Boumpas, Dimitrios T., Kamen, Diane L., Jayne, David, Cervera, R., Costedoat-Chalumeau, Nathalie, Diamond, Betty, Gladman, Dafna D., Hahn, Bevra, Hiepe, Falk, Jacobsen, Søren, Khanna, Dinesh, Lerstrøm, Kirsten, Massarotti, Elena, McCune, Joseph, Ruiz-Irastorza, Guillermo, Sanchez-Guerrero, Jorge, Schneider, Matthias, Urowitz, Murray, Bertsias, George, Hoyer, Bimba F., Leuchten, Nicolai, Schmajuk, Gabriela, Tani, Chiara, Tedeschi, Sara K., Touma, Zahi, Anic, Branimir, Assan, Florence, Chan, Tak Mao, Clarke, Ann Elaine, Crow, Mary K., Czirják, László, Doria, Andrea, Graninger, Winfried, Halda-Kiss, Bernadett, Hasni, Sarfaraz, Izmirly, Peter M., Jung, Michelle, Kumánovics, Gábor, Mariette, Xavier, Padjen, Ivan, Pego-Reigosa, José M., Romero-Diaz, Juanita, Rúa-Figueroa, Íñigo, Seror, Raphaèle, Stummvoll, Georg H., Tanaka, Yoshiya, Tektonidou, Maria G., Vasconcelos, Carlos, Vital, Edward M., Wallace, Daniel J., Yavuz, Sule, Meroni, Pier Luigi, Fritzler, Marvin J., Naden, Ray, Costenbader, Karen, and Johnson, Sindhu R.

Abstract

Background/objectives The European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria for systemic lupus erythematosus system showed high specificity, while attaining also high sensitivity. We hereby analysed the performance of the individual criteria items and their contribution to the overall performance of the criteria. Methods We combined the EULAR/ACR derivation and validation cohorts for a total of 1197 systemic lupus erythematosus (SLE) and n=1074 non-SLE patients with a variety of conditions mimicking SLE, such as other autoimmune diseases, and calculated the sensitivity and specificity for antinuclear antibodies (ANA) and the 23 specific criteria items. We also tested performance omitting the EULAR/ACR criteria attribution rule, which defines that items are only counted if not more likely explained by a cause other than SLE. Results Positive ANA, the new entry criterion, was 99.5% sensitive, but only 19.4% specific, against a non-SLE population that included other inflammatory rheumatic, infectious, malignant and metabolic diseases. The specific criteria items were highly variable in sensitivity (from 0.42% for delirium and 1.84% for psychosis to 75.6% for antibodies to double-stranded DNA), but their specificity was uniformly high, with low C3 or C4 (83.0%) and leucopenia <4.000/mm³ (83.8%) at the lowest end. Unexplained fever was 95.3% specific in this cohort. Applying the attribution rule improved specificity, particularly for joint involvement. Conclusions Changing the position of the highly sensitive, non-specific ANA to an entry criterion and the attribution rule resulted in a specificity of >80% for all items, explaining the higher overall specificity of the criteria set.

Published
2021

40. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?

Author

Hasseli, Rebecca, primary, Pfeil, Alexander, additional, Hoyer, Bimba F., additional, Krause, Andreas, additional, Lorenz, Hanns-Martin, additional, Richter, Jutta G., additional, Schmeiser, Tim, additional, Voll, Reinhard E., additional, Schulze-Koops, Hendrik, additional, Specker, Christof, additional, and Müller-Ladner, Ulf, additional

Published
2021
Full Text
View/download PDF

41. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

Author

Geisen, Ulf M, primary, Berner, Dennis K, additional, Tran, Florian, additional, Sümbül, Melike, additional, Vullriede, Lena, additional, Ciripoi, Maria, additional, Reid, Hayley M, additional, Schaffarzyk, Annika, additional, Longardt, Ann C, additional, Franzenburg, Jeanette, additional, Hoff, Paula, additional, Schirmer, Jan H, additional, Zeuner, Rainald, additional, Friedrichs, Anette, additional, Steinbach, Andrea, additional, Knies, Christine, additional, Markewitz, Robert DH, additional, Morrison, Peter J, additional, Gerdes, Sascha, additional, Schreiber, Stefan, additional, and Hoyer, Bimba F, additional

Published
2021
Full Text
View/download PDF

42. Patient Reported Outcomes in Chronic Inflammatory Diseases: Current State, Limitations and Perspectives

Author

Tran, Florian, primary, Schirmer, Jan Henrik, additional, Ratjen, Ilka, additional, Lieb, Wolfgang, additional, Helliwell, Philip, additional, Burisch, Johan, additional, Schulz, Juliane, additional, Schrinner, Florian, additional, Jaeckel, Charlot, additional, Müller-Ladner, Ulf, additional, Schreiber, Stefan, additional, and Hoyer, Bimba F., additional

Published
2021
Full Text
View/download PDF

45. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

Author

Aringer, Martin, primary, Brinks, Ralph, additional, Dörner, Thomas, additional, Daikh, David, additional, Mosca, Marta, additional, Ramsey-Goldman, Rosalind, additional, Smolen, Josef S, additional, Wofsy, David, additional, Boumpas, Dimitrios T, additional, Kamen, Diane L, additional, Jayne, David, additional, Cervera, R, additional, Costedoat-Chalumeau, Nathalie, additional, Diamond, Betty, additional, Gladman, Dafna D, additional, Hahn, Bevra, additional, Hiepe, Falk, additional, Jacobsen, Søren, additional, Khanna, Dinesh, additional, Lerstrøm, Kirsten, additional, Massarotti, Elena, additional, McCune, Joseph, additional, Ruiz-Irastorza, Guillermo, additional, Sanchez-Guerrero, Jorge, additional, Schneider, Matthias, additional, Urowitz, Murray, additional, Bertsias, George, additional, Hoyer, Bimba F, additional, Leuchten, Nicolai, additional, Schmajuk, Gabriela, additional, Tani, Chiara, additional, Tedeschi, Sara K, additional, Touma, Zahi, additional, Anic, Branimir, additional, Assan, Florence, additional, Chan, Tak Mao, additional, Clarke, Ann Elaine, additional, Crow, Mary K, additional, Czirják, László, additional, Doria, Andrea, additional, Graninger, Winfried, additional, Halda-Kiss, Bernadett, additional, Hasni, Sarfaraz, additional, Izmirly, Peter M, additional, Jung, Michelle, additional, Kumánovics, Gábor, additional, Mariette, Xavier, additional, Padjen, Ivan, additional, Pego-Reigosa, José M, additional, Romero-Diaz, Juanita, additional, Rúa-Figueroa, Íñigo, additional, Seror, Raphaèle, additional, Stummvoll, Georg H, additional, Tanaka, Yoshiya, additional, Tektonidou, Maria G, additional, Vasconcelos, Carlos, additional, Vital, Edward M, additional, Wallace, Daniel J, additional, Yavuz, Sule, additional, Meroni, Pier Luigi, additional, Fritzler, Marvin J, additional, Naden, Ray, additional, Costenbader, Karen, additional, and Johnson, Sindhu R, additional

Published
2021
Full Text
View/download PDF

46. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases

Author

Hasseli, Rebecca, primary, Mueller-Ladner, Ulf, additional, Hoyer, Bimba F, additional, Krause, Andreas, additional, Lorenz, Hanns-Martin, additional, Pfeil, Alexander, additional, Richter, Jutta, additional, Schäfer, Martin, additional, Schmeiser, Tim, additional, Strangfeld, Anja, additional, Schulze-Koops, Hendrik, additional, Voll, Reinhard E, additional, Specker, Christof, additional, and Regierer, Anne Constanze, additional

Published
2021
Full Text
View/download PDF

48. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19

Author

Bernardes, Joana P., primary, Mishra, Neha, additional, Tran, Florian, additional, Bahmer, Thomas, additional, Best, Lena, additional, Blase, Johanna I., additional, Bordoni, Dora, additional, Franzenburg, Jeanette, additional, Geisen, Ulf, additional, Josephs-Spaulding, Jonathan, additional, Köhler, Philipp, additional, Künstner, Axel, additional, Rosati, Elisa, additional, Aschenbrenner, Anna C., additional, Bacher, Petra, additional, Baran, Nathan, additional, Boysen, Teide, additional, Brandt, Burkhard, additional, Bruse, Niklas, additional, Dörr, Jonathan, additional, Dräger, Andreas, additional, Elke, Gunnar, additional, Ellinghaus, David, additional, Fischer, Julia, additional, Forster, Michael, additional, Franke, Andre, additional, Franzenburg, Sören, additional, Frey, Norbert, additional, Friedrichs, Anette, additional, Fuß, Janina, additional, Glück, Andreas, additional, Hamm, Jacob, additional, Hinrichsen, Finn, additional, Hoeppner, Marc P., additional, Imm, Simon, additional, Junker, Ralf, additional, Kaiser, Sina, additional, Kan, Ying H., additional, Knoll, Rainer, additional, Lange, Christoph, additional, Laue, Georg, additional, Lier, Clemens, additional, Lindner, Matthias, additional, Marinos, Georgios, additional, Markewitz, Robert, additional, Nattermann, Jacob, additional, Noth, Rainer, additional, Pickkers, Peter, additional, Rabe, Klaus F., additional, Renz, Alina, additional, Röcken, Christoph, additional, Rupp, Jan, additional, Schaffarzyk, Annika, additional, Scheffold, Alexander, additional, Schulte-Schrepping, Jonas, additional, Schunk, Domagoj, additional, Skowasch, Dirk, additional, Ulas, Thomas, additional, Wandinger, Klaus-Peter, additional, Wittig, Michael, additional, Zimmermann, Johannes, additional, Busch, Hauke, additional, Hoyer, Bimba F., additional, Kaleta, Christoph, additional, Heyckendorf, Jan, additional, Kox, Matthijs, additional, Rybniker, Jan, additional, Schreiber, Stefan, additional, Schultze, Joachim L., additional, Rosenstiel, Philip, additional, Banovich, Nicholas E., additional, Desai, Tushar, additional, Eickelberg, Oliver, additional, Haniffa, Muzlifa, additional, Horvath, Peter, additional, Kropski, Jonathan A., additional, Lafyatis, Robert, additional, Lundeberg, Joakim, additional, Meyer, Kerstin, additional, Nawijn, Martijn C., additional, Nikolic, Marko, additional, Ordovas Montanes, Jose, additional, Pe’er, Dana, additional, Tata, Purushothama Rao, additional, Rawlins, Emma, additional, Regev, Aviv, additional, Reyfman, Paul, additional, Samakovlis, Christos, additional, Schultze, Joachim, additional, Shalek, Alex, additional, Shepherd, Douglas, additional, Spence, Jason, additional, Teichmann, Sarah, additional, Theis, Fabian, additional, Tsankov, Alexander, additional, van den Berge, Maarten, additional, von Papen, Michael, additional, Whitsett, Jeffrey, additional, Zaragosi, Laure Emmanuelle, additional, Angelov, Angel, additional, Bals, Robert, additional, Bartholomäus, Alexander, additional, Becker, Anke, additional, Bezdan, Daniela, additional, Bonifacio, Ezio, additional, Bork, Peer, additional, Clavel, Thomas, additional, Colme-Tatche, Maria, additional, Diefenbach, Andreas, additional, Dilthey, Alexander, additional, Fischer, Nicole, additional, Förstner, Konrad, additional, Frick, Julia-Stefanie, additional, Gagneur, Julien, additional, Goesmann, Alexander, additional, Hain, Torsten, additional, Hummel, Michael, additional, Janssen, Stefan, additional, Kalinowski, Jörn, additional, Kallies, René, additional, Kehr, Birte, additional, Keller, Andreas, additional, Kim-Hellmuth, Sarah, additional, Klein, Christoph, additional, Kohlbacher, Oliver, additional, Korbel, Jan O., additional, Kurth, Ingo, additional, Landthaler, Markus, additional, Li, Yang, additional, Ludwig, Kerstin, additional, Makarewicz, Oliwia, additional, Marz, Manja, additional, McHardy, Alice, additional, Mertes, Christian, additional, Nöthen, Markus, additional, Nürnberg, Peter, additional, Ohler, Uwe, additional, Ossowski, Stephan, additional, Overmann, Jörg, additional, Peter, Silke, additional, Pfeffer, Klaus, additional, Poetsch, Anna R., additional, Pühler, Alfred, additional, Rajewsky, Niklaus, additional, Ralser, Markus, additional, Rieß, Olaf, additional, Ripke, Stephan, additional, Nunes da Rocha, Ulisses, additional, Saliba, Antoine-Emmanuel, additional, Sander, Leif Erik, additional, Sawitzki, Birgit, additional, Schiffer, Philipp, additional, Schulte, Eva-Christina, additional, Sczyrba, Alexander, additional, Stegle, Oliver, additional, Stoye, Jens, additional, Vehreschild, Janne, additional, Vogel, Jörg, additional, von Kleist, Max, additional, Walker, Andreas, additional, Walter, Jörn, additional, Wieczorek, Dagmar, additional, and Ziebuhr, John, additional

Published
2020
Full Text
View/download PDF

49. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD

Author

Hasseli, Rebecca, primary, Mueller-Ladner, Ulf, additional, Schmeiser, Tim, additional, Hoyer, Bimba F, additional, Krause, Andreas, additional, Lorenz, Hanns-Martin, additional, Regierer, Anne Constanze, additional, Richter, Jutta G, additional, Strangfeld, Anja, additional, Voll, Reinhard E, additional, Pfeil, Alexander, additional, Schulze-Koops, Hendrik, additional, and Specker, Christof, additional

Published
2020
Full Text
View/download PDF

50. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

Author

Johnson, Sindhu R, primary, Brinks, Ralph, additional, Costenbader, Karen H, additional, Daikh, David, additional, Mosca, Marta, additional, Ramsey-Goldman, Rosalind, additional, Smolen, Josef S, additional, Wofsy, David, additional, Boumpas, Dimitrios T, additional, Kamen, Diane L, additional, Jayne, David, additional, Cervera, R, additional, Costedoat-Chalumeau, Nathalie, additional, Diamond, Betty, additional, Gladman, Dafna D, additional, Hahn, Bevra, additional, Hiepe, Falk, additional, Jacobsen, Søren, additional, Khanna, Dinesh, additional, Lerstrøm, Kirsten, additional, Massarotti, Elena, additional, McCune, Joseph, additional, Ruiz-Irastorza, Guillermo, additional, Sanchez-Guerrero, Jorge, additional, Schneider, Matthias, additional, Urowitz, Murray, additional, Bertsias, George, additional, Hoyer, Bimba F, additional, Leuchten, Nicolai, additional, Tani, Chiara, additional, Tedeschi, Sara K, additional, Touma, Zahi, additional, Schmajuk, Gabriela, additional, Anic, Branimir, additional, Assan, Florence, additional, Chan, Tak Mao, additional, Clarke, Ann Elaine, additional, Crow, Mary K, additional, Czirják, László, additional, Doria, Andrea, additional, Graninger, Winfried B, additional, Halda-Kiss, Bernadett, additional, Hasni, Sarfaraz, additional, Izmirly, Peter M, additional, Jung, Michelle, additional, Kumánovics, Gábor, additional, Mariette, Xavier, additional, Padjen, Ivan, additional, Pego-Reigosa, José M, additional, Romero-Diaz, Juanita, additional, Rúa-Figueroa, Íñigo, additional, Seror, Raphaèle, additional, Stummvoll, Georg H, additional, Tanaka, Yoshiya, additional, Tektonidou, Maria G, additional, Vasconcelos, Carlos, additional, Vital, Edward M, additional, Wallace, D J, additional, Yavuz, Sule, additional, Meroni, Pier Luigi, additional, Fritzler, Marvin J, additional, Naden, Ray, additional, Dörner, Thomas, additional, and Aringer, Martin, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results